SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-002937
Filing Date
2017-05-10
Accepted
2017-05-10 17:27:15
Documents
74
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051017p.htm 10-Q 815586
2 EXHIBIT 10.6 exh_106.htm EX-10.6 22073
3 EXHIBIT 10.7 exh_107.htm EX-10.7 14712
4 EXHIBIT 31.1 exh_311.htm EX-31.1 6708
5 EXHIBIT 31.2 exh_312.htm EX-31.2 6728
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3485
  Complete submission text file 0001171843-17-002937.txt   5241839

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE args-20170331.xml EX-101.INS 850862
8 XBRL SCHEMA FILE args-20170331.xsd EX-101.SCH 71130
9 XBRL CALCULATION FILE args-20170331_cal.xml EX-101.CAL 21173
10 XBRL DEFINITION FILE args-20170331_def.xml EX-101.DEF 501363
11 XBRL LABEL FILE args-20170331_lab.xml EX-101.LAB 396060
12 XBRL PRESENTATION FILE args-20170331_pre.xml EX-101.PRE 518087
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35443 | Film No.: 17831650
SIC: 2834 Pharmaceutical Preparations